• ALKS Stock Surges 15% On Lilly-Centessa Buyout Igniting Sleep Pipeline Hopes Stocktwits Thu, 09 Jul 2026 06:56:38 GMT
• Is Alkermes (ALKS) Fully Priced As Russell 2000 Index Inclusion Draws Fresh Attention? simplywall.st Thu, 09 Jul 2026 05:00:40 GMT
• Enterprise value to EBITDA forward of Alkermes plc – NASDAQ:ALKS TradingView Tue, 07 Jul 2026 20:38:01 GMT
• enterprise value to ebitda forward of alkermes public limited company – fwb:8ak TradingView Tue, 07 Jul 2026 05:26:35 GMT
• Alkermes stock hits 52-week high at 55.28 USD By Investing.com Investing.com UK Mon, 06 Jul 2026 20:00:00 GMT
• The Bull Case For Alkermes (ALKS) Could Change Following Vibrance-12 Data And Russell 2000 Inclusion simplywall.st Sat, 04 Jul 2026 07:57:22 GMT
• price to earnings forward of alkermes public limited company – xetr:8ak TradingView Fri, 03 Jul 2026 12:49:34 GMT
• enterprise value to revenue forward of alkermes public limited company – xetr:8ak TradingView Fri, 03 Jul 2026 12:37:27 GMT
• Mizuho raises Alkermes stock price target to $65 on narcolepsy drug potential Investing.com Thu, 02 Jul 2026 10:21:40 GMT
• Mizuho Securities Maintains Alkermes(ALKS.US) With Buy Rating, Raises Target Price to $65 Moomoo Thu, 02 Jul 2026 01:32:00 GMT
• alkermes (alks) r&d chief exercises 5,000 options and sells 9,000 shares Stock Titan Wed, 01 Jul 2026 22:29:53 GMT
• alkermes (alks) shows multiple 9,000-share insider sales, exercise and vesting Stock Titan Wed, 01 Jul 2026 20:13:23 GMT
• alks stock surges 15% on lilly-centessa buyout igniting sleep pipeline hopes Stocktwits Wed, 01 Jul 2026 08:52:18 GMT
• Alkermes (ALKS) Is Up 9.3% After Strong Alixorexton Phase 2 Data And Russell 2000 Addition - What's Changed Yahoo Finance Tue, 30 Jun 2026 07:00:00 GMT
• Wells Fargo Keeps Their Buy Rating on Alkermes (ALKS) The Globe and Mail Tue, 30 Jun 2026 07:00:00 GMT
• a look at alkermes plc (alks) after 4.8% decline -- gf value $31 GuruFocus Mon, 29 Jun 2026 23:25:03 GMT
• alkermes faces risk on orexin-related value from upcoming updates, bofa says 富途牛牛 Mon, 29 Jun 2026 16:51:31 GMT
• alks maintained by wells fargo -- price target raised to $65.00 GuruFocus Mon, 29 Jun 2026 15:06:14 GMT
• alks downgraded by b of a securities -- rating changed to underp GuruFocus Mon, 29 Jun 2026 13:09:24 GMT
• wells fargo maintains alkermes(alks.us) with buy rating, raises target price to $65 Moomoo Mon, 29 Jun 2026 10:31:00 GMT
• Alkermes (ALKS) Advances Alixorexton As Valuation Debate Follows Phase 2 Narcolepsy Data simplywall.st Mon, 29 Jun 2026 07:00:00 GMT
• BofA downgrades Alkermes stock rating on valuation concerns Investing.com Mon, 29 Jun 2026 07:00:00 GMT
• Enterprise value to EBIT forward of Alkermes plc – NASDAQ:ALKS TradingView Sun, 28 Jun 2026 16:32:45 GMT
• price to book forward of alkermes public limited company – ls:a1jkvh TradingView Sun, 28 Jun 2026 09:23:56 GMT
• enterprise value to ebitda forward of alkermes public limited company – ls:a1jkvh TradingView Sun, 28 Jun 2026 08:34:47 GMT
• enterprise value to revenue forward of alkermes public limited company – ls:a1jkvh TradingView Sat, 27 Jun 2026 22:12:09 GMT
• alks stock surges 15% on lilly-centessa buyout igniting sleep pipeline hopes Stocktwits Sat, 27 Jun 2026 12:04:15 GMT
• Why Alkermes (ALKS) Is Up 22.4% After Strong Phase 2 Narcolepsy Data For Alixorexton simplywall.st Sat, 27 Jun 2026 04:24:48 GMT
• Alkermes’ incoming CEO has a plan to outplay Lilly and Takeda BioPharma Dive Fri, 26 Jun 2026 07:00:00 GMT
• what does the recent insider sale by alkermes' vp of finance signify Kavout | AI Fri, 26 Jun 2026 06:08:51 GMT
• alkermes | 144: notice of proposed sale of securities pursuant to rule 144 Moomoo Fri, 26 Jun 2026 01:07:26 GMT
• alkermes stock hits 52-week high at 51.77 usd by investing.com Investing.com Nigeria Thu, 25 Jun 2026 16:32:03 GMT
• needham maintains alkermes(alks.us) with buy rating, raises target price to $61 Moomoo Wed, 24 Jun 2026 10:31:00 GMT
• alkermes plc (alks) shares surge 4.3% -- what gf score of 70 tel GuruFocus Wed, 24 Jun 2026 02:48:10 GMT
• analysts offer insights on healthcare companies: beta bionics, inc. (bbnx), regeneron (regn) and alkermes (alks) The Globe and Mail Tue, 23 Jun 2026 11:10:00 GMT
• td cowen maintains alkermes(alks.us) with buy rating, maintains target price $50 Moomoo Mon, 22 Jun 2026 12:33:00 GMT
• deutsche bank lifts alkermes price target to $60 from $47, maintains buy rating Moomoo Mon, 22 Jun 2026 12:06:37 GMT
• alkermes (alks) stock near fair value after positive alixorexton phase 2 results simplywall.st Mon, 22 Jun 2026 11:27:57 GMT
• alkermes plc (alks) stock analysis: navigating growth in biopharmaceuticals with a 4.88% upside DirectorsTalk Interviews Mon, 22 Jun 2026 09:25:09 GMT
• did positive vibrance-2 data for alixorexton just shift alkermes' (alks) investment narrative? simplywall.st Fri, 19 Jun 2026 17:35:20 GMT
• jefferies maintains alkermes(alks.us) with buy rating, raises target price to $59 富途牛牛 Fri, 19 Jun 2026 10:14:39 GMT
• Alkermes: "Buy" On Avadel Acquisition And Positive NT2 Data With Alixorexton (NASDAQ:ALKS) Seeking Alpha Fri, 19 Jun 2026 07:00:00 GMT
• alkermes stock hits 52-week high at 45.76 usd by investing.com Investing.com South Africa Fri, 19 Jun 2026 00:16:29 GMT
• micron to rally around 44%? here are 10 top analyst forecasts for thursday Benzinga Thu, 18 Jun 2026 14:31:38 GMT
• alkermes stock hits 52-week high at 45.76 usd by investing.com Investing.com UK Thu, 18 Jun 2026 13:38:00 GMT
• alkermes (alks) study results highlight potential benefits for n GuruFocus Thu, 18 Jun 2026 12:35:45 GMT
• alks maintains buy rating by needham -- price target raised to $54.00 GuruFocus Thu, 18 Jun 2026 11:34:39 GMT
• alkermes plc (alks) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 07:29:13 GMT
• New Data on Alixorexton for Narcolepsy Type 2: Insights From Richard K. Bogan, MD Psychiatric Times Thu, 18 Jun 2026 07:00:00 GMT
• needham raises alkermes stock price target on narcolepsy drug data Investing.com Thu, 18 Jun 2026 07:00:00 GMT
• h.c. wainwright reiterates alkermes stock rating on trial data Investing.com Thu, 18 Jun 2026 07:00:00 GMT
• alkermes presents detailed positive results from vibrance-2 phase 2 study of alixorexton in adults with narcolepsy type 2 at sleep... BioSpace Thu, 18 Jun 2026 06:30:22 GMT
• alkermes plc (alks) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 05:56:07 GMT
• alkermes plc (alks) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 05:29:37 GMT
• alkermes plc (alks) earnings forecast: future eps & revenue growth estimates TradingKey Thu, 18 Jun 2026 05:25:31 GMT
• alkermes plc (alks) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 04:48:59 GMT
• what does the recent insider sale by alkermes' vp of finance signify Kavout Thu, 18 Jun 2026 03:05:09 GMT
• alkermes (alks) shares fall 31% despite positive phase 2 trial r GuruFocus Thu, 18 Jun 2026 02:54:37 GMT
• alkermes (alks) advances narcolepsy treatment with positive phas GuruFocus Thu, 18 Jun 2026 02:20:45 GMT
• alkermes (alks) advances narcolepsy treatment with positive phas GuruFocus Wed, 17 Jun 2026 22:16:27 GMT
• alkermes (alks) shares fall 31% despite positive phase 2 trial r GuruFocus Wed, 17 Jun 2026 22:16:27 GMT
• alkermes plc (alks) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 21:25:28 GMT
• scientific,investigation,of,a,human,brain,model,with,a,magnifying Pharmaceutical Business review - Wed, 17 Jun 2026 21:10:09 GMT
• alkermes plc (alks) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 21:04:55 GMT
• alixorexton for the treatment of narcolepsy type 2: insights from sleep 2026 Psychiatric Times Wed, 17 Jun 2026 20:28:45 GMT
• Alkermes Presents Detailed Positive Results From Vibrance-2 Phase 2 Study of Alixorexton in Adults With Narcolepsy Type 2 at SLEEP... Yahoo Finance Wed, 17 Jun 2026 07:00:00 GMT
• Sleep Disorder Drugs That Target Brain Circuitry Show Promise Bloomberg.com Wed, 17 Jun 2026 07:00:00 GMT
• Alkermes stock jumps as narcolepsy drug hits trial goals Investing.com Wed, 17 Jun 2026 07:00:00 GMT
• alkermes reports positive phase 2 results for narcolepsy drug Investing.com Wed, 17 Jun 2026 07:00:00 GMT
• scientific,investigation,of,a,human,brain,model,with,a,magnifying Pharmaceutical Business review - Tue, 16 Jun 2026 10:41:53 GMT
• Alkermes’ alixorexton secures FDA and EC orphan designations Pharmaceutical Technology Tue, 16 Jun 2026 07:00:00 GMT
• Alkermes Granted Orphan Drug Designations for Alixorexton in US, Europe Sleep Review Tue, 16 Jun 2026 07:00:00 GMT
• alkermes receives transatlantic orphan drug designations for alixorexton grafa.com Mon, 15 Jun 2026 14:40:39 GMT
• new narcolepsy drug wins rare-disease backing in u.s., europe Stock Titan Mon, 15 Jun 2026 11:00:00 GMT
• alkermes plc (alks) stock analysis: growth potential with a 28.20% revenue surge DirectorsTalk Interviews Mon, 15 Jun 2026 09:22:50 GMT
• Alkermes Announces Orphan Drug Designations for Alixorexton in the U.S. and Europe Yahoo Finance Mon, 15 Jun 2026 07:00:00 GMT
• Alkermes’ alixorexton receives orphan drug designations in US, EU Investing.com Mon, 15 Jun 2026 07:00:00 GMT
• alkermes (alks) wins orphan drug designations in u.s. and europe for alixorexton Stock Titan Mon, 15 Jun 2026 07:00:00 GMT
• alkermes (alks) stock valuation after new orphan drug designation for alixorexton simplywall.st Sun, 14 Jun 2026 10:21:12 GMT
• why (alks) price action is critical for tactical trading Stock Traders Daily Sat, 13 Jun 2026 16:48:02 GMT
• insider sell: christopher wright sells 2,000 shares of alkermes plc (alks) GuruFocus Sat, 13 Jun 2026 02:44:19 GMT
• alkermes (alks) director sells 2,000 shares under rule 10b5-1 plan Stock Titan Sat, 13 Jun 2026 00:18:29 GMT
• alkermes plc (alks) rule 144 notice: 2,000 vested rsu shares listed Stock Titan Fri, 12 Jun 2026 20:19:32 GMT
• Alkermes (ALKS) director sells 2,000 shares under Rule 10b5-1 plan Stock Titan Fri, 12 Jun 2026 07:00:00 GMT
• alkermes' alixorexton gains fda orphan drug status for idiopathic hypersomnia MSN Fri, 12 Jun 2026 03:27:00 GMT
• alkermes (alks) receives fda orphan designation for alixorexton GuruFocus Fri, 12 Jun 2026 03:19:19 GMT
• alkermes (alks) receives orphan drug designation for alixorexton GuruFocus Fri, 12 Jun 2026 00:11:15 GMT
• alkermes (alks) receives orphan drug designation for alixorexton GuruFocus Thu, 11 Jun 2026 19:07:30 GMT
• alkermes (alks) receives fda orphan designation for alixorexton GuruFocus Thu, 11 Jun 2026 18:11:15 GMT
• should alkermes’ (alks) sleep-medicine pivot after lumryz and alixorexton data require investor action? simplywall.st Thu, 11 Jun 2026 17:31:21 GMT
• alks: orexin agonist program advances with strong clinical data, strategic acquisition, and leadership transition TradingView Wed, 10 Jun 2026 15:37:21 GMT
• alks: orexin agonist advances, avadel integration, and pipeline expansion drive strategic momentum TradingView Wed, 10 Jun 2026 15:02:54 GMT
• Alkermes Touts Orexin Ambitions as Alixorexton Enters Phase 3 and CEO Transition Nears Yahoo Finance Wed, 10 Jun 2026 07:00:00 GMT
• alkermes stock hits 52-week high at 44.58 usd by investing.com Investing.com Australia Wed, 10 Jun 2026 05:31:41 GMT
• alkermes plc (alks) shares surge 4.4% -- what gf score of 74 tel GuruFocus Wed, 10 Jun 2026 00:46:04 GMT
• alkermes stock hits 52-week high at 44.58 usd by investing.com Investing.com Nigeria Tue, 09 Jun 2026 19:05:17 GMT
• alks maintained by rbc capital -- price target raised to $56.00 GuruFocus Tue, 09 Jun 2026 16:41:15 GMT
• rbc raises price target on alkermes to $56 from $45, keeps outperform rating Moomoo Tue, 09 Jun 2026 10:57:17 GMT
• Alkermes Jumps 5.6% After RBC Capital Maintains Outperform AlphaStreet Tue, 09 Jun 2026 07:00:00 GMT
• rbc capital raises alkermes stock price target on pipeline potential Investing.com Tue, 09 Jun 2026 07:00:00 GMT
• alkermes' orexin may have applicability outside sleep, rbc says Moomoo Tue, 09 Jun 2026 07:00:00 GMT
• alkermes plc (alks) stock analysis: strong buy ratings and promising growth potential DirectorsTalk Interviews Mon, 08 Jun 2026 09:21:48 GMT
• should alkermes’ stronger q1 2026 results and sleep-medicine advances prompt action from alks investors? Yahoo Finance Mon, 08 Jun 2026 03:08:00 GMT
• alkermes to present new data on alixorexton and lumryz® (sodium oxybate) at sleep 2026, highlighting breadth of sleep medicine res... MSN Sun, 07 Jun 2026 08:09:15 GMT
• Should Alkermes’ Stronger Q1 2026 Results and Sleep-Medicine Advances Prompt Action From ALKS Investors? Yahoo Finance Sun, 07 Jun 2026 07:00:00 GMT
• alkermes to participate in the goldman sachs 47th annual global healthcare conference MSN Sat, 06 Jun 2026 23:56:11 GMT
• current ratio of alkermes public limited company – xetr:8ak TradingView Sat, 06 Jun 2026 20:34:21 GMT
• cash from financing activities of alkermes public limited company – xetr:8ak TradingView Sat, 06 Jun 2026 20:21:13 GMT
• alkermes public limited company balance sheet – xetr:8ak TradingView Sat, 06 Jun 2026 13:30:22 GMT
• insider sell alert: david gaffin sells shares of alkermes plc GuruFocus Fri, 05 Jun 2026 02:07:00 GMT
• a look at alkermes (alks) valuation after 28.2% revenue growth and strengthening analyst optimism simplywall.st Fri, 05 Jun 2026 01:36:51 GMT
• alks stock surges 15% on lilly-centessa buyout igniting sleep pipeline hopes Stocktwits Fri, 05 Jun 2026 00:57:16 GMT
• alkermes (alks) showcases sleep medicine research at sleep 2026 GuruFocus Fri, 05 Jun 2026 00:53:46 GMT
• Alkermes (ALKS) Up 21.1% Since Last Earnings Report: Can It Continue? Yahoo Finance Thu, 04 Jun 2026 07:00:00 GMT
• what does the recent insider sale by alkermes' vp of finance signify Kavout | AI Thu, 04 Jun 2026 07:00:00 GMT
• alkermes to present narcolepsy drug data at sleep 2026 Investing.com Thu, 04 Jun 2026 07:00:00 GMT
• new narcolepsy and hypersomnia treatment data from alkermes at sleep 2026 Stock Titan Thu, 04 Jun 2026 07:00:00 GMT
• alkermes (alks) evp gaffin sells 2,034 shares under 10b5-1 plan Stock Titan Thu, 04 Jun 2026 07:00:00 GMT
• alkermes plc (alks) shares surge 3.5% -- what gf score of 75 tel GuruFocus Thu, 04 Jun 2026 02:26:15 GMT
• alkermes to participate in the goldman sachs 47th annual global healthcare conference MSN Thu, 04 Jun 2026 00:43:07 GMT
• alks stock price, quote & chart | alkermes plc (nasdaq:alks) ChartMill Wed, 03 Jun 2026 22:28:35 GMT
Alkermes plc(NASDAQ:ALKS) 
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA (aripiprazole lauroxil), an e...
Website: http://www.alkermes.com
Founded: 1987
Full Time Employees: 2,235
Sector: Healthcare
Industry: Biotechnology